MBNL1 and RBFOX2 cooperate to establish a splicing programme involved in pluripotent stem cell differentiation

Nature Communications

Volumn 4, Issue , 2013, Pages

  Venables, Julian P ^a,b,c   Lapasset, Laure ^a,c,d,e   Gadea, Gilles ^c,f   Fort, Philippe ^c,f   Klinck, Roscoe ^g,h   Irimia, Manuel ⁱ   Vignal, Emmanuel ^c,f   Thibault, Philippe ^g   Prinos, Panagiotis ^g   Chabot, Benoit ^g,h   Abou Elela, Sherif ^g,h   Roux, Pierre ^c,f   Lemaitre, Jean Marc ^a,c,d,e   Tazi, Jamal ^a,c  

^a INSTITUT DE GÉNÉTIQUE MOLÉCULAIRE DE MONTPELLIER   (France)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c UNIV MONTPELLIER   (France)

^d INSTITUT DE GÉNOMIQUE FONCTIONNELLE   (France)

^e INSERM   (France)

^f Centre National de la Recherche Scientifique   (France)

^g UNIVERSITÉ DE SHERBROOKE   (Canada)

^h UNIVERSITY OF SHERBROOKE   (Canada)

ⁱ UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATP2A1 PROTEIN; CLSTN1 PROTEIN; FMNL3 PROTEIN; FNIP1 PROTEIN; ITGA6 PROTEIN; KIF13A PROTEIN; MARK2 PROTEIN; NERVE CELL ADHESION MOLECULE; PALM PROTEIN; PLOD2 PROTEIN; PPIP5K1 PROTEIN; PROTEIN; RNA BINDING PROTEIN; RNA BINDING PROTEIN FOX 2; RNA BINDING PROTEIN MUSCLEBLIND; TRANSCRIPTION FACTOR TWIST; UNCLASSIFIED DRUG; UVOMORULIN; MBNL1 PROTEIN, HUMAN; RBFOX2 PROTEIN, HUMAN; REPRESSOR PROTEIN; PROTEIN BINDING;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; CELL ADHESION; CELL DIFFERENTIATION; CELL MIGRATION; CONTROLLED STUDY; EMBRYONIC STEM CELL; EXON; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MESODERM; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; VERTEBRATE; CELL CULTURE; CYTOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; NEWBORN; NUCLEAR REPROGRAMMING; PROTEIN BINDING; SIGNAL TRANSDUCTION;

VERTEBRATA;

ALTERNATIVE SPLICING; CELL DIFFERENTIATION; CELLS, CULTURED; FIBROBLASTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE REGULATORY NETWORKS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; INFANT, NEWBORN; MESODERM; NUCLEAR REPROGRAMMING; PROTEIN BINDING; REPRESSOR PROTEINS; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; CELLULAR REPROGRAMMING;

EID: 84899044116     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms3480     Document Type: Article

References (48)

1. Park, I.-H. et al. Disease-specific induced pluripotent stem cells. Cell 134, 877-886 (2008).
2. Robinton, D. A. & Daley, G. Q. The promise of induced pluripotent stem cells in research and therapy. Nature 481, 295-305 (2012).
3. Wu, S. M. & Hochedlinger, K. Harnessing the potential of induced pluripotent stem cells for regenerative medicine. Nat. Cell Biol. 13, 497-505 (2011).
4. Evseenko, D. et al. Mapping the first stages of mesoderm commitment during differentiation of human embryonic stem cells. Proc. Natl Acad. Sci. USA 107, 13742-13747 (2010).
5. Ramirez, J.-M. et al. Brief report: benchmarking human pluripotent stem cell markers during differentiation into the three germ layers unveils a striking heterogeneity: All markers are not equal. Stem Cells 29, 1469-1474 (2011).
6. Kroon, E. et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat. Biotechnol. 26, 443-452 (2008).
7. Neph, S. et al. Circuitry and dynamics of human transcription factor regulatory networks. Cell 150, 1274-1286 (2012).
8. Loh, Y.-H. et al. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat. Genet. 38, 431-440 (2006).
9. Boyer, L. A. et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122, 947-956 (2005).
10. Maniatis, T. & Tasic, B. Alternative pre-mRNA splicing and proteome expansion in metazoans. Nature 418, 236-243 (2002).
11. Ankö, M.-L. & Neugebauer, K. M. RNA-protein interactions in vivo: global gets specific. Trends Biochem. Sci. 37, 255-262 (2012).
12. Barash, Y. et al. Deciphering the splicing code. Nature 465, 53-59 (2010).
13. Venables, J. P., Tazi, J. & Juge, F. Regulated functional alternative splicing in Drosophila. Nucleic Acids Res. 40, 1-10 (2012).
14. Black, D. L. Mechanisms of alternative pre-messenger RNA splicing. Annu. Rev. Biochem. 72, 291-336 (2003).
15. Ule, J. et al. An RNA map predicting Nova-dependent splicing regulation. Nature 444, 580-586 (2006).
16. Xu, X. et al. ASF/SF2-regulated CaMKIIdelta alternative splicing temporally reprograms excitation-contraction coupling in cardiac muscle. Cell 120, 59-72 (2005).
17. Salomonis, N. et al. Alternative splicing regulates mouse embryonic stem cell pluripotency and differentiation. Proc. Natl Acad. Sci. USA 107, 10514-10519 (2010).
18. Nelles, D. A. & Yeo, G. W. Alternative splicing in stem cell self-renewal and diferentiation. Adv. Exp. Med. Biol. 695, 92-104 (2010).
19. Gabut, M. et al. An alternative splicing switch regulates embryonic stem cell pluripotency and reprogramming. Cell 147, 132-146 (2011).
20. Gopalakrishna-Pillai, S. & Iverson, L. E. A DNMT3B alternatively spliced exon and encoded peptide are novel biomarkers of human pluripotent stem cells. PLoS One 6, e20663 (2011).
21. Schwanhäusser, B. et al. Global quantification of mammalian gene expression control. Nature 473, 337-342 (2011).
22. Venables, J. P. et al. Cancer-associated regulation of alternative splicing. Nat. Struct. Mol. Biol. 16, 670-676 (2009).
23. Venables, J. P. et al. RBFOX2 is an important regulator of mesenchymal tissuespecific splicing in both normal and cancer tissues. Mol. Cell Biol. 33, 396-405 (2013).
24. Lapasset, L. et al. Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state. Genes Dev. 25, 2248-2253 (2011).
25. Xing, Y. & Lee, C. Alternative splicing and RNA selection pressure-evolutionary consequences for eukaryotic genomes. Nat. Rev. Genet. 7, 499-509 (2006).
26. Xing, Y. & Lee, C. J. Protein modularity of alternatively spliced exons is associated with tissue-specific regulation of alternative splicing. PLoS Genet. 1, e34 (2005).
27. Wang, E. T. et al. Alternative isoform regulation in human tissue transcriptomes. Nature 456, 470-476 (2008).
28. Han, H. et al. MBNL proteins repress ES-cell-specific alternative splicing and reprogramming. Nature 498, 241-245 (2013).
29. Wang, E. T. et al. Transcriptome-wide regulation of pre-mRNA splicing and mRNA localization by muscleblind proteins. Cell 150, 710-724 (2012).
30. Rinaldi, F. et al. Aberrant splicing and expression of the non muscle myosin heavychain gene MYH14 in DM1 muscle tissues. Neurobiol. Dis. 45, 264-271 (2012).
31. Lin, X. et al. Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy. Hum. Mol. Genet. 15, 2087-2097 (2006).
32. Kalsotra, A. et al. A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart. Proc. Natl Acad. Sci. USA 105, 20333-20338 (2008).
33. Fugier, C. et al. Misregulated alternative splicing of BIN1 is associated with T tubule alterations and muscle weakness in myotonic dystrophy. Nat. Med. 17, 720-725 (2011).
34. Venables, J. P., Vignal, E., Baghdiguian, S., Fort, P. & Tazi, J. Tissue-specific alternative splicing of Tak1 is conserved in deuterostomes. Mol. Biol. Evol. 29, 261-269 (2012).
35. Shapiro, I. M. et al. An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype. PLoS Genet. 7, e1002218 (2011).
36. Zhang, Z. et al. Divergence of exonic splicing elements after gene duplication and the impact on gene structures. Genome Biol. 10, R120 (2009).
37. Yang, J. et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117, 927-939 (2004).
38. Kimura, T. et al. Altered mRNA splicing of the skeletal muscle ryanodine receptor and sarcoplasmic/endoplasmic reticulum Ca2-ATPase in myotonic dystrophy type 1. Hum. Mol. Genet. 14, 2189-2200 (2005).
39. Hino, S.-I. et al. Molecular mechanisms responsible for aberrant splicing of SERCA1 in myotonic dystrophy type 1. Hum. Mol. Genet. 16, 2834-2843 (2007).
40. Gates, D. P., Coonrod, L. A. & Berglund, J. A. Autoregulated splicing of muscleblind-like 1 (MBNL1) Pre-mRNA. J. Biol. Chem. 286, 34224-34233 (2011).
41. NCBI Resource Coordinators. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 41, D8-D20 (2013).
42. Boué, S., Paramonov, I., Barrero, M. J. & Izpisúa Belmonte, J. C. Analysis of human and mouse reprogramming of somatic cells to induced pluripotent stem cells. What is in the plate? PLoS One 5, e12664 (2010).
43. Pan, Q. et al. Revealing global regulatory features of mammalian alternative splicing using a quantitative microarray platform. Mol. Cell 16, 929-941 (2004).
44. Goers, E. S., Purcell, J., Voelker, R. B., Gates, D. P. & Berglund, J. A. MBNL1 binds GC motifs embedded in pyrimidines to regulate alternative splicing. Nucleic Acids Res. 38, 2467-2484 (2010).
45. Charizanis, K. et al. Muscleblind-like 2-mediated alternative splicing in the developing brain and dysregulation in myotonic dystrophy. Neuron 75, 437-450 (2012).
46. Yeo, G. W. et al. An RNA code for the FOX2 splicing regulator revealed by mapping RNA-protein interactions in stem cells. Nat. Struct. Mol. Biol. 16, 130-137 (2009).
47. Zhang, C. et al. Defining the regulatory network of the tissue-specific splicing factors Fox-1 and Fox-2. Genes Dev. 22, 2550-2563 (2008).
48. Holt, I. et al. Defective mRNA in myotonic dystrophy accumulates at the periphery of nuclear splicing speckles. Genes Cells 12, 1035-1048 (2007).